Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ABCB5 Maintains Melanoma-Initiating Cells through a Proinflammatory Cytokine Signaling Circuit
Brian J. Wilson, Karim R. Saab, Jie Ma, et al.
Cancer Research (2014) Vol. 74, Iss. 15, pp. 4196-4207
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Cancer stem cell (CSC) resistance drivers
Masoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Life Sciences (2019) Vol. 234, pp. 116781-116781
Closed Access | Times Cited: 375
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
Romana-Rea Begicevic, Marco Falasca
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2362-2362
Open Access | Times Cited: 342
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
Heming Zhou, Jigang Zhang, Xue Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 319
Shared genetic and experimental links between obesity-related traits and asthma subtypes in UK Biobank
Zhaozhong Zhu, Yanjun Guo, Huwenbo Shi, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 145, Iss. 2, pp. 537-549
Open Access | Times Cited: 313
Insights into new mechanisms and models of cancer stem cell multidrug resistance
Yoelsis García-Mayea, Cristina Mir, Frédérick Masson, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 166-180
Closed Access | Times Cited: 274
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes
Chloé Chong, Markus Müller, HuiSong Pak, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 262
SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial–mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer
Yin Zhu, Shimiao Huang, Shengyuan Chen, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 120
Cancer Stem Cells—Key Players in Tumor Relapse
Monica Marzagalli, Fabrizio Fontana, M. Raimondi, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 376-376
Open Access | Times Cited: 115
ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance
Jingyi Fan, Kenneth K.W. To, Zhe‐Sheng Chen, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100905-100905
Open Access | Times Cited: 95
Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 53
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells
Youssef Al Hmada, Robert T. Brodell, Naji Kharouf, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 470-470
Open Access | Times Cited: 15
IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma
Ying Qiao, Chunhua Zhang, Aoya Li, et al.
Oncogene (2017) Vol. 37, Iss. 7, pp. 873-883
Closed Access | Times Cited: 142
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
Iris C. Salaroglio, Eleonora Mungo, Elena Gazzano, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2505-2505
Open Access | Times Cited: 142
Resistance to Cell Death and Its Modulation in Cancer Stem Cells
Ahmad R. Safa
Critical Reviews™ in Oncogenesis (2016) Vol. 21, Iss. 3-4, pp. 203-219
Open Access | Times Cited: 127
ABC transporters as cancer drivers: Potential functions in cancer development
Alice Domenichini, Aleksandra Adamska, Marco Falasca
Biochimica et Biophysica Acta (BBA) - General Subjects (2018) Vol. 1863, Iss. 1, pp. 52-60
Closed Access | Times Cited: 120
ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance
Wanjiru Muriithi, Lucy Wanjiku Macharia, Carlos Pilotto Heming, et al.
Cancer Biology and Medicine (2020) Vol. 17, Iss. 2, pp. 253-269
Open Access | Times Cited: 118
Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment
Farhadul Islam, Vinod Gopalan, Robert A. Smith, et al.
Experimental Cell Research (2015) Vol. 335, Iss. 1, pp. 135-147
Closed Access | Times Cited: 116
ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates
Jing‐Quan Wang, Zhuo‐Xun Wu, Yuqi Yang, et al.
Journal of Evidence-Based Medicine (2021) Vol. 14, Iss. 3, pp. 232-256
Closed Access | Times Cited: 101
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?
Axel Schulenburg, Katharina Blatt, Sabine Cerny‐Reiterer, et al.
Journal of Hematology & Oncology (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 92
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
Claudia Maria Hattinger, Maria Pia Patrizio, Leonardo Fantoni, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2878-2878
Open Access | Times Cited: 82
Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies
Markus H. Frank, Brian J. Wilson, Jason S. Gold, et al.
Gastroenterology (2021) Vol. 160, Iss. 6, pp. 1947-1960
Open Access | Times Cited: 71
Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance
Saeedeh Keyvani‐Ghamsari, Khatereh Khorsandi, Azhar Rasul, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 69
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 8
MITF Modulates Therapeutic Resistance through EGFR Signaling
Zhenyu Ji, Y. Erin Chen, Raj Kumar, et al.
Journal of Investigative Dermatology (2015) Vol. 135, Iss. 7, pp. 1863-1872
Open Access | Times Cited: 79
Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment
Elin S. Gray, Anna Reid, Samantha Bowyer, et al.
Journal of Investigative Dermatology (2015) Vol. 135, Iss. 8, pp. 2040-2048
Open Access | Times Cited: 78
Page 1 - Next Page

Scroll to top